At the conclusion of this webinar, the audience should be better able to:
✔️ Define mutation and variant as they relate to SARS-CoV-2.
✔️ Discuss the importance of the current variants and mutations including future predictions surrounding the epidemiology of spread and modeling.
✔️ Describe what is known about SARS-CoV-2 variants’ susceptibility to vaccines and therapeutic antibodies.
🗣️ SPEAKERS:
🔸 James Lawler, MD, MPH, FIDSA, Executive Director of Clinical and Biodefense Research, Global Center for Health Security, Nebraska Medicine
🔸 Anne Piantadosi, MD, PhD, Assistant Professor, Department of Pathology and Laboratory Medicine & practicing Infectious Disease physician in the Department of Medicine, Infectious Disease Division, Emory University
👨💻 MODERATOR:
Radu Postelnicu, MD, Critical Care Medicine, NYC Health + Hospitals/Bellevue
This activity is intended primarily for healthcare workers and teams which may include but are not limited to: medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.
➡️ Get educational credit for this webinar through: https://courses.netec.org/
source
